Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight
Journal of Endocrinological Investigation · 2005-05 · 28 (5) · RC1-RC3
DOI: 10.1007/bf03345372 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 18.03.2014. Verfasst von Pinzone und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Biochemistry and Molecular Biology, The George Washington University School of Public Health …. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Biochemistry and Molecular Biology, The George Washington University School of Public Health and Health Policy Washington, DC, USA.
Zitieren
APA
Pinzone, Fox, M. L., Sastry, M. K., Parenti, D. M., & Simon, G. L. (2005). Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight. Journal of Endocrinological Investigation, 28(5), RC1-RC3. https://doi.org/10.1007/bf03345372
Vancouver
Pinzone, Fox ML, Sastry MK, Parenti DM, Simon GL. Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight. Journal of Endocrinological Investigation. 2005;28(5):RC1-RC3. doi:10.1007/bf03345372
BibTeX
@article{Pinzone2005,
author = {Pinzone and Fox, M L and Sastry, M K and Parenti, D M and Simon, G L},
title = {Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight},
journal = {Journal of Endocrinological Investigation},
year = {2005},
volume = {28},
number = {5},
pages = {RC1--RC3},
doi = {10.1007/bf03345372}
}
EUVIMED